2025
SJR Q1
JCR Q2 · 3,4
251 matched articles
SCIE
Journal detail
Mycoses
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0933740714390507
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,85
- Quartile Q1
- H-Index 95
- Cites/doc 3,38
- Docs (3y) 398
- Cites (3y) 1.471
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,4
- 5Y JIF 3,7
- JCI 1,11
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Dermatology Q1
- Infectious Diseases Q2
- Medicine (miscellaneous) Q2
Areas
- Medicine
WoS categories
- Dermatology | Mycology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,85 | 3,4 | 3,7 | 1,11 | Q1 | 95 |
| 2024 | Q1 | Q2 | 0,927 | 3,1 | 3,5 | 1,31 | Q1 | 91 |
| 2023 | Q1 | Q1 | 0,966 | 4,1 | 4,1 | 1,54 | Q1 | 91 |
| 2022 | Q1 | Q1 | 1,059 | 4,9 | 4,2 | 1,59 | Q1 | 91 |
| 2021 | Q1 | Q1 | 1,022 | 4,9 | 4,3 | 1,52 | Q1 | 91 |
| 2020 | Q1 | Q1 | 1,13 | 4,4 | 3,8 | 1,45 | Q1 | 91 |
| 2019 | Q1 | Q1 | 1,181 | 3,6 | 3,1 | 1,46 | Q1 | 91 |
| 2018 | — | Q2 | — | 3,1 | 2,8 | 1,24 | Q1 | — |
| 2017 | Q1 | Q1 | 1,069 | 2,8 | 2,5 | 1,14 | Q1 | 91 |
| 2016 | Q1 | Q2 | 1,018 | 2,3 | 2,1 | — | — | 91 |
| 2015 | Q1 | Q2 | 0,905 | 2,3 | 1,9 | — | — | 91 |
| 2014 | Q1 | Q2 | 0,824 | 2,2 | 1,9 | — | — | 91 |
| 2013 | Q2 | Q2 | 0,629 | 1,8 | 1,7 | — | — | 91 |
| 2012 | Q2 | Q3 | 0,539 | 1,3 | 1,6 | — | — | 91 |
| 2011 | Q2 | Q2 | 0,585 | 2,2 | 1,9 | — | — | 91 |
| 2010 | Q2 | Q2 | 0,57 | 1,7 | 1,7 | — | — | 91 |
| 2009 | — | Q3 | — | 1,4 | 1,5 | — | — | — |
| 2008 | — | Q3 | — | 1,5 | 1,5 | — | — | — |
| 2007 | — | Q3 | — | 1,3 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 1 | — | — | — | — |
| 2005 | — | Q3 | — | 0,8 | — | — | — | — |
| 2004 | — | Q3 | — | 0,7 | — | — | — | — |
| 2003 | — | Q3 | — | 0,8 | — | — | — | — |
| 2002 | — | Q3 | — | 0,5 | — | — | — | — |
| 2001 | — | Q3 | — | 0,8 | — | — | — | — |
| 2000 | — | Q3 | — | 0,7 | — | — | — | — |
| 1999 | — | Q3 | — | 0,8 | — | — | — | — |
| 1998 | — | Q3 | — | 0,5 | — | — | — | — |
| 1997 | — | Q3 | — | 0,5 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | DERMATOLOGY | SCIE | Q2 | Q2 | 25/99 |
| 2025 | MYCOLOGY | SCIE | Q3 | Q1 | 17/33 |
| 2024 | DERMATOLOGY | SCIE | Q2 | Q1 | 27/96 |
| 2024 | MYCOLOGY | SCIE | Q2 | Q1 | 12/32 |
| 2023 | DERMATOLOGY | SCIE | Q1 | Q1 | 12/94 |
| 2023 | MYCOLOGY | SCIE | Q2 | Q1 | 9/33 |
| 2022 | DERMATOLOGY | SCIE | Q1 | Q1 | 10/70 |
| 2022 | MYCOLOGY | SCIE | Q2 | Q1 | 8/30 |
| 2021 | DERMATOLOGY | SCIE | Q1 | Q1 | 14/69 |
| 2021 | MYCOLOGY | SCIE | Q2 | Q1 | 8/30 |
| 2020 | DERMATOLOGY | SCIE | Q1 | Q1 | 16/69 |
| 2020 | MYCOLOGY | SCIE | Q1 | Q1 | 6/30 |
| 2019 | DERMATOLOGY | SCIE | Q1 | Q1 | 14/68 |
| 2019 | MYCOLOGY | SCIE | Q1 | Q1 | 7/29 |
| 2018 | DERMATOLOGY | SCIE | Q2 | Q1 | 17/66 |
| 2018 | MYCOLOGY | SCIE | Q2 | Q2 | 10/29 |
| 2017 | DERMATOLOGY | SCIE | Q1 | Q1 | 15/64 |
| 2017 | MYCOLOGY | SCIE | Q2 | Q2 | 11/29 |
| 2016 | DERMATOLOGY | SCIE | Q2 | — | 24/63 |
| 2016 | MYCOLOGY | SCIE | Q2 | — | 15/30 |
| 2015 | DERMATOLOGY | SCIE | Q2 | — | 17/61 |
| 2015 | MYCOLOGY | SCIE | Q2 | — | 12/29 |
| 2014 | DERMATOLOGY | SCIE | Q2 | — | 18/63 |
| 2014 | MYCOLOGY | SCIE | Q2 | — | 12/24 |
| 2013 | DERMATOLOGY | SCIE | Q2 | — | 26/61 |
| 2013 | MYCOLOGY | SCIE | Q3 | — | 12/23 |
| 2012 | DERMATOLOGY | SCIE | Q3 | — | 36/59 |
| 2012 | MYCOLOGY | SCIE | Q3 | — | 16/23 |
| 2011 | DERMATOLOGY | SCIE | Q2 | — | 18/58 |
| 2011 | MYCOLOGY | SCIE | Q2 | — | 10/24 |
| 2010 | DERMATOLOGY | SCIE | Q3 | — | 28/55 |
| 2010 | MYCOLOGY | SCIE | Q2 | — | 10/23 |
| 2009 | DERMATOLOGY | SCIE | Q3 | — | 30/48 |
| 2009 | MYCOLOGY | SCIE | Q3 | — | 11/19 |
| 2008 | DERMATOLOGY | SCIE | Q3 | — | 26/43 |
| 2008 | MYCOLOGY | SCIE | Q3 | — | 12/19 |
| 2007 | DERMATOLOGY | SCIE | Q3 | — | 24/41 |
| 2007 | MYCOLOGY | SCIE | Q3 | — | 10/19 |
| 2006 | DERMATOLOGY | SCIE | Q4 | — | 32/39 |
| 2006 | MYCOLOGY | SCIE | Q3 | — | 10/17 |
| 2005 | DERMATOLOGY | SCIE | Q4 | — | 33/39 |
| 2005 | MYCOLOGY | SCIE | Q3 | — | 9/17 |
| 2004 | DERMATOLOGY | SCIE | Q4 | — | 31/38 |
| 2004 | MYCOLOGY | SCIE | Q3 | — | 10/17 |
| 2003 | DERMATOLOGY | SCIE | Q4 | — | 29/38 |
| 2003 | MYCOLOGY | SCIE | Q3 | — | 10/16 |
| 2002 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 34/40 |
| 2002 | MYCOLOGY | SCIE | Q3 | — | 10/15 |
| 2001 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 26/38 |
| 2001 | MYCOLOGY | SCIE | Q3 | — | 10/15 |
| 2000 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 25/36 |
| 2000 | MYCOLOGY | SCIE | Q3 | — | 8/14 |
| 1999 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q3 | — | 22/36 |
| 1999 | MYCOLOGY | SCIE | Q3 | — | 9/15 |
| 1998 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 28/35 |
| 1998 | MYCOLOGY | SCIE | Q3 | — | 9/15 |
| 1997 | DERMATOLOGY & VENEREAL DISEASES | SCIE | Q4 | — | 25/32 |
| 1997 | MYCOLOGY | SCIE | Q3 | — | 11/15 |